draft .pdf

KAAUH DRUG FORMULARYUpdated June 2015

Developed by: Abdullatif Alokifi

Eman AlMutairi

Acknowledgment Sincere thanks to those who contributed to the development and review of this formulary:

Ahlam Al-duhaish Atheer Al-harbi Haifa Al-Rabiah Haila Alrakaf Khalid Al-Harbi Lamya Al-Issa Lina Al-Ghamdy Maliha Al-sufyan Maram AlMutairi Nouf Alsaban Najla Alabdulkareem Sara Alqahtani

Inquiries should be directed to: Pharmaceutical Care Services [email protected] 011-8203021 011-8203029 From Sunday to Thursday, 7:30 a.m. to 4:30 a.m.

Introduction

Preface

How to use this Formulary

Summary of changes (Amendments, deletions)

Formulary, P&T Committee

Addition of New Medication to KAAUH Formulary

Request for non-formulary medication for a specific patient

Controlled Medicat List

Narcotic Medication List

High Alert Medications (HAMs) List

Look-Alike and Sound-Alike Medications

Concentrated Electrolytes

Adult Crash Cart Medication List

Pediatric Crash Cart Medication List

Emergency Box medication list

Drug Recall

The AHFS Pharmacologic-Therapeutic Classification4:00 - Antihistamine Drugs

8:00 - Anti-infective Agents

10.00 - Antineoplastic Agents

12.00 - Autonomic Drugs

Table of Content

16:00 - Blood Derivatives

20:00 - Blood Formation, Coagulation, and Thrombosis

24:00 - Cardiovascular Drugs

28:00 - Central Nervous System Agents

36:00 - Diagnostic Agents

40.00 - Electrolytic, Caloric, and Water Balance

44.00 - Enzymes

48.00 - Respiratory Tract Agents

52:00 - Eye, Ear, Nose, and Throat (EENT) Preparation

56.00 - Gastrointestinal Drugs

64:00 - Heavy Metal Antagonists

68:00 - Hormones and Synthetic Substitutes

72:00 - Local Anesthetics

76:00 - Oxytocics

80:00 - Serums, Toxoids, and Vaccines

84:00 - Skin and Mucous Membrane Agents

86:00 - Smooth Muscle Relaxants

88:00 - Vitamins

92:00 - Miscellaneous Therapeutic Agents

94:00 Devices

96:00 Pharmaceutical Aids

Alphabetical Classification

Introduction: KAAUH Formulary is a continually updated list of medications and related information, representing the clinical judgment of physicians, pharmacists and other healthcare professionals, used in the treatment and/or diagnosis of disease and promotion of health. It should be evidence based, reflecting international guidelines, and cost effective to serve the health interests of the local population.

The aim of developing a formulary for King Abdullah bin Abdulaziz University Hospital is to serve as a guide for physicians, prescribers, and other health care professionals.

Preface: Drugs are listed in KAAUH Formulary by Pharmacologic-Therapeutic Classification. The American Hospital Formulary Service (AHFS) classification system was used in this formulary. This classification system is one of the most recognized methods for systemic classification of medications. Drugs are listed by generic name. Some brand names are included as a reference to assist in product recognition.

How to use this Formulary: There are two ways to find your drug within the formulary:

1 . By P h arm aco lo g ic-T h e rap e u tic C lassif icatio n

For example drugs used to treat a heart condition are listed under the category 2 4 :0 0 C ard io vascular D rug s. If you know what your drug is used for, look for the category name in the table of content, then look under the category name for your drug.

2 . By A lp h ab e tical l ist

If you are not sure what category to look under, you should look for your drug in the Alphabetical list.

Formulary A formulary is a continually updated list of medications and related information, representing the clinical judgment of physicians, pharmacists, and other experts in the diagnosis, prophylaxis, or treatment of disease and promotion of health. A formulary includes, but is not limited to, a list of medications and medication-associated products or devices, medication-use policies, important ancillary drug information, decision-support tools, and organizational guidelines.

P&T Committee The P&T committee is responsible for managing the formulary system. It is composed of actively practicing physicians, other prescribers, pharmacists, nurses, administrators, quality improvement managers, and other health care professionals and staff who participate in the medication-use process. The P&T committee should be responsible for:

% Overseeing policies and procedures related to all aspects of medication use. % To the medical staff as a whole. % Medication-use evaluation (MUE). % Adverse-drug-event monitoring and reporting. % Medication-error prevention. % Development of clinical care plans and guidelines.

Addition of New Medication to KAAUH Formulary Replacement of existing drugs and superiority over existing drugs are two important areas for Committee consideration. In order to control the growth of the formulary, it is preferred that each addition be balanced by a deletion when practical. In any case, the Committee must be provided with a published scientific journal article (not an advertisement) demonstrating the efficacy of the new drug. Restricted use of a drug is possible if it is felt that a drug should only be used by certain members of the Medical Staff. This would mean that Pharmacy would not honor orders for the drug by non-approved physicians. Use rate of the new drug is essential to insure that reasonable quantities to insure both an adequate supply for regular, sustained use as well as to prevent ordering an excessive quantity that will never be used. Even though a drug is accepted for addition to the Formulary, it will not be ordered until this information is provided in a suitable form. The requesting physician should get the signatures of his Department Head before submitting the completed form to pharmacy and therapeutic coordinator .The requesting physician will be notified of the date and time of the Committee meeting to consider the request and may be invited to attend to lend support.

Evaluating Medications for Inclusion in the Formulary The P&T committee should use a structured, evidence-based process in the evaluation of medications for formulary consideration. The P&T committee should be provided with information that reflects a thorough, accurate, and unbiased review and analysis of the evidence available in the scientific literature. The evaluation process should encourage objective consideration of clinical and care delivery information, facilitate communication, foster positive patient outcomes, and support safe and effective medication ordering, dispensing, administration, and monitoring. Decisions made by the P&T committee should support improved patient care outcomes across the continuum of care.

Pharmacy and Therapeutics Committee

(Please read the instructions on the reverse side before filling the form)

Generic Name:____________________________________________________________ Trade Name :_____________________________________________________________ Dosage Form(s):____________________________________ Strength(s):_____________ Manufacturer (if known):____________________________________________________ Pharmacological Classification: Class:________________ Sub Class: ________________ Therapeutic Use(s):________________________________________________________________________________________________________________________________________________________________________________________________________________________What drugs, currently in the formulary, will be replaced?___________________________ How is requested drug superior to existing formulary drugs? ________________________ _________________________________________________________________________ _________________________________________________________________________

Should this drug be restricted to use by certain members of the Medical Staff? If so, whom and why?

__________________________________________________________________________ __________________________________________________________________________ What will be the anticipated use rate if this drug is added to the formulary?: _________________________________________________________________________ _________________________________________________________________________ =================================================================

REQUESTED BY: Name: ___________________________ Specialty:________________ Signature: ___________________________Date: _________________

APPROVED BY: Department Head: ___________________________________________ Signature: ____________________________ Date: _________________ ================================================================== PHARMACY USE ONLY: Registration/Availability Status/ Drug Evaluation:___________

Price: ______________________________________________ ================================================================== COMMITTEE ACTION: APPROVED:_____NOT APPROVED_______Date:_________ Requestor notified of action on (date): ___________________________________________

P & T Committee Chairmans Signature

INSTRUCTIONS FOR COMPLETION OF THE FORM 1. Formulary addition / deletion request form is to be completed by requester when requesting the addition of a medication to the formulary.

2. The form must be filled in legibly in ink, preferably typed, by the physician 3. Replacement of existing drugs and superiority over existing drugs are two important areas for Committee consideration. In order to control the growth of the formulary, it is preferred that each addition be balanced by a deletion when practical. In any case, the Committee must be provided with a published scientific journal article (not an advertisement) demonstrating the efficacy of the new drug. 4. Restricted use of a drug is possible if it is felt that a drug should only be used by certain members of the Medical Staff. This would mean that Pharmacy would not honor orders for the drug by non-approved physicians. 5. Use rate of the new drug is essential to insure that reasonable quantities to insure both an adequate supply for regular, sustained use as well as to prevent ordering an excessive quantity that will never be used. This information must be in some form that can be readily used to arrive at the quantity to be ordered. A statement such as two ampoules per patient visit and ten patients per month is necessary. Even though a drug is accepted for addition to the Formulary, it will not be ordered until this information is provided in a suitable form.

6. The requesting physician should get the signatures of his Department Head before submitting the completed form to pharmacy and therapeutic coordinator . The requesting physician will be notified of the date and time of the Committee meeting to consider the request and may be invited to attend to lend support. 7. Formulary addition / deletion requests should have non-company sponsored literature, and a summary of the literature attached for members review.

8. The requestor will also be notified of the Committees action and will be notified when the medication is actually on hand ready to be used.

Requesting a Non-Formulary Medication for a specific patient Non-formulary medications shall not be dispensed by the pharmacy department unless the item is not readily available in the community and only obtained for in-house patients if a similar item or combination of items is not presently on the formulary. Non-formulary medications may only be requested by the attending physician, utilizing the "Request for nonformulary medication for a specific patinets, form shall be reviewed by Drug Information pharmacist and approved by the Director of pharmacy. !

Urgent Non-Urgent

Patient Name:

Inpatient Outpatient MRN:

Date of Request Patient Age Patient Weight

Please read the instructions on the next page before filling the form

I. Drug Related Information Generic Name Brand Name

Dosage Form Strength Frequency Period of Treatment

Justification for the Request:

Requested By: Physician Name Specialty

Signature Ext. No. Mobile No. Date Time

II. Pharmacy Use Only: Received By Pharmacist: Date Time

Section: Signature Bleep/Ext. No.

III. Director of Pharmacy / Drug Information Pharmacist:

Approved Disapproved

Comment:

Requester Notified of Action on (Date):

Kindly complete this form and submit it to Pharmaceutical Care Department

PHARMACEUTICAL CARE DEPARTMENT

REQUEST FOR NON-FORMULARY MEDICATION FOR A SPECIFIC PATIENT

INSTRUCTIONS AND GENERAL INFORMATION

1. Non-Formulary request is to be completed by Physician when requesting a specific medication for a specific. (This is not a request for addition to the formulary)

2. Non-Formulary request must include; complete review of patient history, scientific justification, submission of the treatment protocol, supporting literature, and completed SFDA justification form for non-registered items.

3. Only ORIGINAL Non-Formulary Request will be accepted and processed for drug evaluation.

4. The form must be filled out LEGIBLY by the requesting prescriber (one patient per form).

5. The Director of Pharmacy / Drug Information Pharmacist will evaluate the request and provide

the medication which will take maximum 10 working days from the date of receiving the request.

6. For urgent request, the drug will be available within 24 hours or less according to the availability of the drug.

7. For urgent requests consider, if the drug is a life-threatening agent or a Patient Owned Medication (POM) that is out of stock and the patient cannot discontinue the medication suddenly, or other serious condition.

8. For Patient Own Medication, the prescriber will request it as Non-Formulary Request which will

be provided within 5 days, if it is applicable.

9. Consultants are reminded to request special medications only as a last resort when there is no

alternative medication in the formulary.

10. The Medications requested through this form will be dispensed only to those patients for whom they have been requested. (Medications WILL NOT be dispensed to other patients even when being treated by the requesting physician).

11. Requesting Physician will be notified when the medication is available.

12. For unclaimed out-patient, the expiry date for the request is one month from its date of approval.

PHARMACEUTICAL CARE DEPARTMENT

Controlled Medication

Item # Generic Name Conc. Volume Dosage form 1 Diazepam 5 mg 2ml Ampoule 2 Midazolam 5 mg 3ml Ampoule 3 Midazolam 5 mg 10ml Ampoule 4 Ethanol 5 mg 5ml Ampoule 5 Pentobarbital 3 mg 500ml Bottle 6 Pentobarbital 4 mg 473ml Bottle 7 Phenobarbital 3 mg 100ml Bottle 8 Alprazolam 0.5 mg --- Tablet 9 Clonazepam 2 mg --- Tablet

10 Clonazepam 0.5 mg --- Tablet 11 Diazepam 10 mg 0ml Rectal Tube 12 Diazepam 5 mg --- Tablet 13 Diazepam 5 mg 0ml Rectal Tube 14 Lorazepam 1 mg --- Tablet 15 Lorazepam 2 mg 1ml Ampoule 16 Lorazepam 2 mg --- Tablet 17 Methylphenidate 18 mg --- Tablet 18 Methylphenidate 36 mg --- Tablet 19 Methylphenidate 10 mg --- Tablet 20 Phenobarbital 100 mg --- Tablet 21 Phenobarbital 200 mg 1ml Ampoule 22 Phenobarbital 60 mg 1ml Ampoule 23 Thiopental 500 mg 1ml VIAL 24 Nalbuphine 20 mg 1ml Ampoule 25 Benzhexol 2 mg --- Tablet 26 Benzhexol 5 mg --- Tablet 27 Clobazam 10 mg --- Tablet 28 Ephedrine 50 mg 1ml Ampoule 29 Ketamine 500 mg 10ml Ampoule 30 Chlordiazepoxide 5 mg --- Tablet 31 Chloral Hydrate 40 mg 500ml Bottle 32 Chloral Hydrate 100 mg 500ml Bottle 33 Zolpidem 10 mg --- Tablet 34 Hydroxyzine 10 mg --- Tablet 35 Phenobarbital 10 mg --- Tablet 36 Pentobarbital 30 mg --- Tablet 37 Alprazolam 0.25 mg --- Tablet 38 Clonazepam 2.5 mg 10ml Ampoule 39 Ephedrine 30 mg 1ml Ampoule 40 Phenobarbital 60 mg --- Tablet

Narcotic Medication:

Item # Generic Name Conc. Volume Dosage form 1 Fentanyl 0.05 mg 2ml Ampoule 2 Fentanyl 0.05 mg 10ml Ampoule 3 Fentanyl 4.2 mg --- Patch 4 Fentanyl 8.4 mg --- Patch 5 Fentanyl 16.8 mg --- Patch 6 Morphine 10 mg 1ml Ampoule 7 Morphine 2 mg 500ml Bottle 8 Pethidine 50 mg 2ml Ampoule 9 Pethidine 50 mg 1ml Ampoule

10 Tramadol 50 mg 2ml Ampoule 11 Tramadol 50 mg --- Capsule 12 Tramadol 100 mg --- Capsule 13 Alfentanil 0.5 mg 2ml Ampoule 14 Codeine 30 mg --- Tablet 15 Oxycodone 5 mg --- Tablet 16 Remifentanil 2 mg 1ml VIAL 17 Remifentanil 5 mg 1ml VIAL 18 Sufentanil 0.05 mg 2ml Ampoule 19 Morphine 10 mg --- Tablet 20 Morphine 30 mg --- Tablet 21 Methadone 5 mg --- Tablet 22 Tramadol 100 mg --- Suppository

High Alert Medications (HAMs) List

Adrenergic Agonists (IV) Epinephrine Phenylephrine Ephedrine Isoproterenol Norepinephrine Adrenergic Antagonists (IV) Propranolol Metoprolol Esmolol Verapamil Labetalol Atenolol Anesthetic Agents (General, inhaled and IV) Propofol Ketamine Desflurane Sevoflurane Etomidate Antiarrhythmics Procainamide (IV) Quinidine (PO) Lidocaine (IV) Phenytoin (PO, IV) Amiodarone (IV) Bretylium Adenosine (IV) Antithrombotic Agents Warfarin (PO) Enoxaparin (SC) Heparin (IV) Alteplase (IV) Streptokinase (IV) Chemotherapeutic Agents Methotrexate (PO, IV) Hydroxyurea (PO) Azathioprine (PO) Interferon beta 1a Interferon beta 1b Epidural or intrathecal medications Bupivacaine Bupivacaine Heavy Oral Hypoglycemics Metformin (PO) Gliclazide MR (PO) Glimepiride (PO) Glibenclamide (PO) Pioglitazone (PO) Acarbose (PO) Inotropic Medications Milrinone (IV) Digoxin (PO, IV) DOPamine (IV) DOBUTamine (IV) Phentolamine (IV) Moderate sedation agents Midazolam (IV) Chloral Hydrate (PO) Ketamine (IV, IM) Narcotics/Opioids Fentanyl Pethidine Morphine Tramadol

Cont. High Alert Medications (HAMs) ListCont. High Alert Medications (HAMs) List

Neuromuscular Blockers (IV) Atracurium Succinylcholine Pancronium Rocuronium Electrolytes (IV) Potassium Chloride 2 mEq/mL or higher concentration

Sodium Chloride 3% or higher concentration

Potassium Phosphate 3 mmol/mL or higher conc

Sodium Acetate 2 mEq/mL or higher concentration

Potassium Acetate 2 mEq/mL or higher concentration

Sodium Phosphate 3 mmol/mL or higher concentration

Magnesium Sulfate, all concentrations Vasodilators Hydralazine (PO, IV) Nitroglycerin (IV, PO) Nitroprusside (IV) General Groups ALL Chemotherapeutic Agents (IV & Oral) Anesthetic Agents intravenous, inhaled and general ALL Opiates & Narcotics (All routes) Dialysis Solutions (Peritoneal & Hemodialysis) ALL Intrathecal or Epidural Agents Cardioplegic Solutions ALL oral hypoglycemics Miscellaneous Drugs Dextrose 50% (IV) Oxytocin (IV) Insulin (All routes) Vasopressin (IV) Promethazine (IV) Total Parenteral Nutrition (TPN) Dextrose 50% (IV) Liposomal forms of drugs carBAMazepine Sterile water for injection, inhalation, and irrigation

in containers of 100 mL or greater

Look-Alike and Sound-Alike Medications A list of Look-Alike, Sound-Alike Medications is identified, maintained and reviewed annually.Tallman lettering labels must be used for all Look-Alike, Sound-Alike Medications to ensure medication safety. All Look-Alike, Sound-Alike Medications should be stored in an individual containers with orange labels and separated from one another. All staff involved in the medication process shall be educated on look-alike sound-alike medications.

Concentrated Electrolytes KAAUH must maintain patient safety measures to reduce the risk of errors related to the medication use process, in regard to concentrated electrolytes. As concentrated electrolytes are High Alert Medications, the safeguards outlined in the APP High Alert Medication Guidelines are applicable (e.g.. Independent Double Checking, Medication Segregation, etc).

Drug Name Confused Drug Name acetaZOLAMIDE

acetoHEXAMIDE

ALPRAZolam

- LORazepam - MIDAZOLam - CLONAzepam - DIAZEPam

Adult Crash Cart Medication List Medications Adenosine 3mg/ml ( 2ml) vial Amiodarone 50 mg/ml ampoule ( 3ml) Atropine 0.5mg premixed syringe ( 0.1mg/ml) (5ml) Calcium chloride 10% premixed syringe (100gm/ml) ( 10ml) Dextrose 50% vial ( 50ml) Dopamine 400mg/250ml D5W premixed bag Epinephrine 1:10000 (10ml) (premixed) Epinephrine 1mg ampule Lidocaine 2% premixed syringe (20mg/ml) ( 5ml) Magnesium sulfate 50% ampoule Nor epinephrine 1mg/ ml ampoule ( 4ml) Sodium bicarbonate 8.4% premixed syringe ( 50ml) Sodium chloride 0.9% 10 ml ampule Vasopressin 20 Unit /ml vial ( 1ml ) Procainamide 100mg /ml ampoule ( 10ml)

Pediatric Crash Cart Medication List Medications Adenosine 3mg/ml ( 2ml) vial Amiodarone 50 mg/ml ampoule ( 3ml) Atropine 0.5mg premixed syringe ( 0.1mg/ml) (5ml) Calcium chloride 10% premixed syringe (100gm/ml) ( 10ml) Dextrose 50% vial ( 50ml) Dopamine 400mg/250ml D5W premixed bag Epinephrine 1:10000 (10ml) (premixed) Epinephrine 1mg ampule Lidocaine 2% premixed syringe (20mg/ml) ( 5ml) Magnesium sulfate 50% ampoule Nor epinephrine 1mg/ ml ampoule ( 4ml) Sodium bicarbonate 8.4% vial ( 50ml) Water for Injection (10ml ) Procainamide 100mg /ml ampoule ( 10ml) Sodium chloride 0.9% 10 ml ampule Naloxone 0.4mg/ml, 1ml ampoule

Emergency Box medication list

Medications Atropine 0.5mg premixed syringe ( 0.5mg/5ml) Sodium bicarbonate 8.4% vial ( 50ml) Procainamide 1000mg /10ml ampoule Naloxone 0.4mg/ml ampoule Adenosine 6mg/2ml vial Sterile water for injection 10ml Amiodarone 150 mg/3ml ampoule Calcium chloride 10% premixed syringe (1000mg/10ml) Calcium gluconate 10% 10ml Dextrose 50% vial ( 50ml) Dopamine 400mg/250ml D5W premixed bag Dobutamine Hcl 250mg/10ml Epinephrine 1:10000 (1mg/10ml) (premixed) Epinephrine 1mg/1ml ampule Lidocaine 2% premixed syringe (100mg/5ml) Magnesium sulfate 50% ampoule Nor-epinephrine 4mg/ 4ml ampoule Phenytoin 250mg IV (5ml) Vial Digoxin 0.5mg/2ml I.V Injection Furosemide 20mg/2ml ampule Sodium chloride 0.9% 10 ml ampule Vasopressin 20 Unit /ml vial Verapamil 5mg/2ml injection Diphenhydramine 50mg/1ml vial Propranolol 1mg/1ml I.V Vial Dextrose 10% 500ml IV in bottle Flumazenil injection 0.5mg/5ml Hydrocortisone 100mg I.V Ampoule Normal saline 0.9% 500ml bag Refrigerated Isoproterenol Hcl 1:5000 (0.2mg/1ml) Ampoule Glucagon 1mg ( 1unit) vial+ solvent in prefilled syringe

Drug Recall Drug Recall: is the process by which medication declared contaminated, mislabeled or dangerous by the manufacturers, national, international drug control body, is retrieved from various storage and dispensing areas of the hospital both inpatient and ambulatory care areas. There are three classes in which recalled are placed relative to its potential harm. The recalled classes are as follows:

C lass I: This recall is for dangerous or defective products that could cause serious health problems or death. This class is the most serious and requires immediate action. You should remove the product(s) from service. C lass I I : This recall class is for products that might cause a temporary health problem, or pose only a slight threat of a serious nature. You should identify and take corrective action regarding the product(s).

C lass I I I : This recall class is for product(s) that are unlikely to cause any adverse health reaction, but that are in violation of SFDA or equivalent regulatory agency regulations. This class requires identifying the product(s) and recognizing its potential harm

When a recall or discontinuation notice is received from FDA, SFDA, Manufacturer or any equivalent regulatory agency, the drug(s) in question must immediately be removed from all storage areas to ensure that the drug(s) is/are not available for use. Prescriptions must be checked to determine if any prescription has been dispensed with the lot number in question. The medical staff are notified through the Pharmaceutical Care department that a recall notice has been received for a particular drug.

Reporting of Adverse Drug Reaction (ADR) Adverse Drug Reaction and Medication Errors can be reported through our Hospital medication safety program (MSP) [email protected]

The AHFS Pharmacologic-Therapeutic Classification Was developed and is maintained by the American Society of Health-System Pharmacists (ASHP). ASHP is the national professional association that represents pharmacists who practice in inpatient, outpatient, home-care, and long-term-care settings. ASHP has a long history of fostering evidence-based medication use as well as patient medication safety. The following table lists the AHFS Classification. All marketed drug products fall under one or more of these classifications:

AHFS Class Number AHFS Class Description 4:00 Antihistamine Drugs 8:00 Anti-infective Agents 10:00 Antineoplastic Agents 12:00 Autonomic Drugs 16:00 Blood Derivatives 20:00 Blood Formation, Coagulation, and Thrombosis Agents 24:00 Cardiovascular Drugs 26:00 Cellular Therapy 28:00 Central Nervous System Agents 32:00 Contraceptives (foams, devices) 34:00 Dental Agents 36:00 Diagnostic Agents 38:00 Disinfectants (for agents used on objects other than skin) 40:00 Electrolytic, Caloric, and Water Balance 44:00 Enzymes 48:00 Respiratory Tract Agents 52:00 Eye, Ear, Nose, and Throat (EENT) Preparations 56:00 Gastrointestinal Drugs 60:00 Gold Compounds 64:00 Heavy Metal Antagonists 68:00 Hormones and Synthetic Substitutes 72:00 Local Anesthetics 76:00 Oxytocics 78:00 Radioactive Agents 80:00 Serums, Toxoids, and Vaccines 84:00 Skin and Mucous Membrane Agents 86:00 Smooth Muscle Relaxants 88:00 Vitamins 92:00 Miscellaneous Therapeutic Agents 94:00 Devices 96:00 Pharmaceutical Aids

KAAUH DRUG FORMULARY By AHFS PHARMACOLOGIC/THERAPEUTIC CLASSES

Updated June 2015

4:00 - Antihistamine Drugs CLASS/DRUG STRENGTH FORM STATUS

4:04 - First Generation Antihistamines

4:04.04 Ethanolamine Derivatives

DiphenhydrAMINE, Ammonium chloride, Menthol

14MG, 135MG, 1.1MG

Syrup LASA

DiphenhydrAMINE, Menthol 7MG, 0.55MG Syrup

DiphenhydrAMINE 50MG/ML, 1ML Injection LASA

25MG Capsule

4:04.12 Phenothiazine Derivatives

Promethazine 25MG/ML, 2ML Injection HAM

4:08 - Seconed Generation Antihistamines Loratidine 1 mg / ml Syrup

10 MG Tablet

Loratadine, Pseudoephedrine 5MG, 120MG Tablet

Dimethindene Maleate Gel

Oral Drops

8:00 - Anti-infective Agents

8:00 - Anti-infective Agents CLASS/DRUG STRENGTH FORM STATUS

8:08 AnthelminticsAlbendazole 200mg Tablet AUR

400mg Tablet AUR

Mebendazole 100MG Tablet AUR

8:12 - Antibacterials

8:12.02 - Aminoglycosides

Amikacin 500MG/2ML Injection

Gentamicin 80MG/2ML Ampule LASA

8:12.06 - Cephalosporins

8:12.06.04 - First Generation Cephalosporins

CeFAZolin Sodium 1 GM Vial LASA

Cephalexin 250 MG/5ML Suspension

8:12.06.08 - Second Generation Cephalosporins

Cefuroxime 125MG/5ML Suspension

250MG/5ML Suspension


Cefuroxime Axetil 250 MG Tablet

Cefuroxime Axetil 500 MG Tablet

8:12.06.12 - Third Generation Cephalosporins

Cefotaxime 500MG Vial

CefTAZidime Injection 1 GM Vial LASA

CefTRIAXone 1 GM Vial LASA

8:12.06.16 Fourth Generation Cephalosporins

Cefepime 1 GM Vial AUR

8:12.07 - Miscellaneous -Lactams

8:12.07.08 - Carbapenems

Meropenem 1 GM Injection

500 MG Injection

Imipenem and Cilastatin 500 MG Vial AUR

8.12.08 - Chloramphenicol

Chloramphenicol 0.5%,10ML Eye Drops

1% Eye Ointment


8:12.12 - Macrolides

8:12.12.04 - Erythromycins

Erythromycin 250 MG Tablet

0.50% 3.5G Eye Ointment

Erythromycin ethylsuccinate 200 MG BASE/5 ML 100 ML

Suspension

8:12.12.92 - Other Macrolides

Azithromycin 200 MG/5 ML, 15 ML

Suspension

250 MG film coated Tablet

500 MG Vial

Clarithromycin 125MG/5ML Suspension

250 MG Tablet

500 MG Tablet

8:12.16 - Penicillins

8:12.16.04 - Natural Penicillins

Penicillin G 1,000,000 I.U. Injection

Penicillin Phenoxymethyl potassium

250 MG/5 ML IN 100 ML

Suspension


8:12.16.12 - Penicillinase-resistant Penicillins

Cloxacillin or Flucloxacillin 250 MG Vial

250MG Capsule

125MG/5ML Syrup AUR

8:12.16.08 - Aminopenicillins

Amoxicillin 250MG Capsule


500 MG Capsule

Ampicillin 1GM Injection

250MG Injection

Amoxicillin, Clavulanic acid 400MG/ 57MG per 5ML

Suspension

250MG/125MG Tablet

500MG/100MG Vial

875 MG, 125MG Tablet

Amoxicillin, pot. Clavulanate 500MG/125MG Tablet

Amoxicillin, Clavulanic acid as potassium

125MG+31.25MG/5ML

Suspension

8:12.16.16 - Extended-spectrum Penicillins

Piperacillin Sodium, Tazobactam Sodium (Tazocin)

4 GM, 500 MG Vial


Amoxicillin 250MG Capsule


500 MG Capsule

Ampicillin 1GM Injection

250MG Injection

Amoxicillin, Clavulanic acid 400MG/ 57MG per 5ML

Suspension

250MG/125MG Tablet

500MG/100MG Vial

875 MG, 125MG Tablet

Amoxicillin, pot. Clavulanate 500MG/125MG Tablet

Amoxicillin, Clavulanic acid as potassium

125MG+31.25MG/5ML

Suspension

Piperacillin Sodium, Tazobactam Sodium (Tazocin)

4 GM, 500 MG Vial

8:12.18 - Quinolones

Ciprofloxacin 200MG/100ML Solution for infusion

250MG Tablet

500MG Tablet

Levofloxacin 500MG/100ML Injection


Moxifloxacin 400MG Tablet

0.50% Eye Drops

400MG Injection AUR

8:12.20 - Sulfonamides

Co-trimoxazole 800/160MG Tablet

400MG/80MG Ampoule

Co-trimoxazole Paediatric 40 MG,200 MG/5ML, 50ML

Suspension

SulfaSALAzine 500MG Tablet LASA

8:12.24 Tetracyclines

Doxycycline 100MG Tablet

8:12.24.12 Glycylcyclines

Tigecycline 50MG Vial

8:12.28 - Antibacterials, Miscellaneous

8:12.28.20 Lincomycins

Clindamycin Injection 300 MG/2 ML Ampoule

Clindamycin Injection 600 MG/4 ML Ampoule AUR

Clindamycin 150 MG Capsule


Clindamycin 1% Topical Solution

2% 40G Vaginal Cream

8:12.28.16 Glycopeptides

Vancomycin HCL 1 G Vial

500 MG Vial

8:12.28.24 Oxazolidinones

Linezolid 2MG/ML, 300ML

Injection

8:12.28.28 Polymyxins

Colistine 150mg Vial AUR

8:12.28.30 Rifamycins

Rifampicin 150MG Capsule

300MG Capsule

Rifampicin , Isoniazid 300MG/150MG Tablet

Rifampicin 300MG Vial


8:14 - Antifungals

8:14.08 - Azoles

Fluconazole 150MG Capsule

2MG/ML Vial

10MG/ML Suspension

Itraconazole 100MG Capsule

10MG/ML 25ML Injection

10MG/ML Oral Solution

Ketoconazole 2%, 120ML Shampoo

2% (20MG/GM) 30GM

Cream

Voriconazole 200MG Tablet

8:14.16 Echinocandins

Caspofungin 50 MG Vial AUR

70 MG Vial AUR

8:14.28 - Polyenes

Amphotericin B 50 MG Injection LASA

Amphotericin-B Liposomal 50 Mg Injection AUR, LASA


Nystatin 15GRAMS Cream LASA

15GRAMS Ointment LASA

8:14.92 - Antifungals, Miscellaneous

Griseofulvin 125MG Tablet

125 MG/ 120ML Syrup

8:16 - Antimycobacterials

8:16.04 - Antituberculosis Agents

Ethambutol 400MG Tablet LASA

Isoniazid 100MG Tablet

300MG Tablet

Pyrazinamide 500MG Tablet

8:16.92 Antimycobacterials, Miscellaneous

Dapsone 25MG Tablet AUR

100MG Tablet AUR


8:18 Antiviral

8:18.04 Adamantanes

Amantadine 100MG Capsule LASA

8:18.20 Interferons

Interferon Beta-1a. 12 M.I.U. Injection

30 MCG Injection

6 M.I.U. Injection

Interferon Beta-1b 9.6 M.I.U. Injection

8:18.28 Neuraminidase Inhibitors

Oseltamivir 75MG Capsule

8:18.32 Nucleosides and Nucleotides

Acyclovir 200MG Tablet

200MG/5ML Syrup

3%,4.5 GRAM Eye Ointment


Acyclovir 400MG Tablet

250Mg Powder For Infusion

Vial

Famciclovir 250 MG Tablet AUR

Ganciclovir Vial 500 MG Tablet AUR

ValACYclovir 500MG Tablet LASA

8:30 Antiprotozoals

8:30.08 - Antimalarials

Pyrimethamine 25MG Tablet

Hydroxychloroquine 200MG Tablet

8:30.04 - Amebicides

MetroNIDAZOLE 500MG/100 ML Injection LASA

8:36 - Urinary Anti-infectives Nitrofurantoin 100MG Tablet

25MG/5 ML, 60 ML

Syrup


8:30.92 Antiprotozoals, Miscellaneous

MetroNIDAZOLE 500 MG Vaginal Suppository

LASA

125MG/5ML (120ML)

Suspension LASA

250MG Tablet LASA

500 MG Tablet LASA

10. Antineoplastic Agents

10. Antineoplastic AgentsCLASS/DRUG STRENGTH FORM STATUS

Methotrexate 2.5 MG Tablet

20MG Pre-filled syringe

Hydroxyurea Capsules 500 MG Capsule

Interferon Beta 1a 12 M.I.U. Injection

30 MCG Injection

6 M.I.U. Injection

Interferon Beta-1b 9.6 M.I.U. Injection

Mitomycine-C 20MG Vial AUR

12. Autonomic Drugs

12. Autonomic Drugs CLASS/DRUG STRENGTH FORM STATUS

12:04. Parasymathomimetic (Cholinergic) Agents

Neostigmine 2.5MG/ML Ampoule

Neostigmine Methyl sulphate 0.5 MG/ML IN 1 ML

Ampoule

Physostigmine salicylate 2 MG Ampoule

12:08. Anticholinergic Agents

12:08.08 - Antimuscarinics/Antispasmodics

Atropine Sulfate 0.1MG/ML, (10ML)

Pre-filled syringe

Atropine Sulphate 0.1Mg/Ml (5Ml) Prefilled Syringe

Atropine Sulfate 0.5MG Ampoule

Atropine Sulfate 1MG/ML Ampoule

Glycopyrrolate 0.2 MG/ML Vial

1MG Tablet

Butylscopolamine (Hyoscine-N-Butyl Bromide)

1MG/ML Syrup

10 MG Tablet

20 MG/1 ML Vial

Ipratropium Bromide ,Fenoterol Hydrobromide

20 MCG/50 MCG

Metered-dose inhaler

Ipratropium Bromide 20MCG/PUFF Inhaler

250MCG/2ML Vial

500MCG/2ML Ampoule


12:12. Symapthomimetic (Adrenergic) Agents

12:12.04: alpha-Adrenergic Agonists

Phenylephrine 2.5% 5ML Eye Drops HAM

Injection HAM

12:12.08 BETA ADRENERGIC AGONISTS

12:12.08.12 Selective Beta2-Adrenergic Agonists

Formoterol Fumarate Dihydrate, Budesonide

4.5 MCG/160 MCG

Turbohaler

Salbutamol (Albuterol) 0.5%, 20 ML Nebulizer Solution

100 MCG/PUFF Inhaler

500 MCG / ML INJECTION

Salmeterol xinafoate, Fluticasone propionate

25 MCG, 250 MCG/PUFF

Evohaler

25 MCG, 50 MCG

Evohaler

50 MCG, 250 MCG

Diskus

25 MCG, 125 MCG

Evohaler

12:12.08.08 Selective Beta1-Adrenergic Agonists

DOBUTamine 500MG IN 250ML D5W

Premixed Bag

HAM, LASA

250 MG Injection HAM, LASA

DOPamine HCl 400MG, 250ML D5W

Premixed Bag

HAM, LASA


DOPamine HCl 800MG, 250MG D5W

Premixed Bag

HAM, LASA

40 MG/ML IN 5 ML (200 MG)

Vial HAM, LASA

12:12.08.04 Non-Selective Beta-Adrenergic Agonists

Isoprenaline HCL (Isoproterenol)

200 MCG/ML Ampoule HAM

12:12.12 Alpha And Beta Adrenergic Agonists

EPINEPHrine 1:1000(1MG/1ML),1ML

Injection HAM, LASA

Epinephrine For Adult 0.3MG(1:1000) Auto-Injector

HAM, LASA

Epinephrine (For Pediatrics Anaphylactic Shock)

150MCG HAM, LASA

EPINEPHrine 1:10000 (0.1MG/1ML), 10ML

Injection HAM, LASA

ePHEDrine sulphate 50MG/ML - 1ML Injection HAM, LASA

30MG Ampoule HAM, LASA

12:16. Sympatholytic (Adrenergic Blocking) Agents

12:16.04. alpha-Adrenergic Blocking Agents

12:16.04.04. Non-selective alpha-Adrenergic Blocking Agents

Phentolamine 10MG/ML Injection


Ergotamine Tartrate, Caffeine 1 MG, 100 MG Tablet

Norepinephrine (Noradrenaline) acid tartrate Injection

1MG/ML, 4 ML Ampoule HAM

12:16.04.08. Non-selective alpha-1-Adrenergic Blocking Agents

Terazosin 2MG Tablet

12:16.04.12. Selective alpha-1-Adrenergic Blocking Agents

Tamsulosin MR 0.4 MG Tablet

12:16.08. beta-Adrenergic Blocking Agents

12:16.08.04. Non-selective beta-Adrenergic Blocking Agents

Carvedilol 12.5MG Tablet LASA

25MG Tablet LASA

6.25MG Tablet LASA

Propranolol 1MG/ML Injection HAM

10MG Tablet

40MG Tablet


Labetalol 100MG Tablet

5MG/ML, 20ML Injection HAM

12:16.08.08. Selective beta-Adrenergic Blocking Agents

Atenolol 100MG Tablet

50MG Tablet

25MG Tablet

Bisoprolol 10MG Tablet

5MG Tablet

2.5MG Tablet

Esmolol 10MG/ML, 10ML

Vial HAM

Metoprolol 100MG Tablet


50MG Tablet

12:20. Skeletal Muscle Relaxants

12:20.04 CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS

TiZANidine 2MG Tablet

4MG Tablet


Chlorzoxazone , Acetaminophen

250MG, 300MG Capsule

12:20.08 DIRECT-ACTING SKELETAL MUSCLE RELAXANTS

Dantrolene Sodium 25MG Capsule

20MG Vial

12:20.12 GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS

Baclofen 10MG Tablet

12:20.20: Neuromuscular Blocking Agents

Atracurium Besylate 10 MG/ML, 2.5 ML

Ampoule

Cisatracurium 2MG\ML Solution

Pancuronium Bromide 2MG/ML Ampoule

Rocuronium Bromide 10 MG/ML Injection

Succinylcholine 100MG/2ML Injection

16:00 - Blood Derivatives

16:00 - Blood DerivativesCLASS/DRUG STRENGTH FORM STATUS

Albumin Human 5%, 250ML BAG

20%, 50ML BOTTLE

20:00 - Blood Formation, Coagulation, and Thrombosis

20:00 - Blood Formation, Coagulation, and ThrombosisCLASS/DRUG STRENGTH FORM STATUS

20:04 - Antianemia Drugs

20:04.04. Iron Preparations

Ferric hydroxide polymaltose complex

50MG/5ml Syrup

Ferrous 100MG Tablet

Ferrous Salt (60-70 MG Elemental iron)

200MG Tablet

Ferrous sulphate folic acid 150MG, 0.5MG Capsule

Ferrous sulphate 15MG/0.6ML ,50ML

Oral Drops

Iron Saccharate 100MG/5ML Injection

20:04.08. Liver and Stomach Preparations

Cyanocobalamin (B12) 500MCG Tablet

500MCG Ampoule

1000 MCG/ML Vial

20:12. Antithrombotic Agents

20:12.04. Anticoagulants

20:12.04.08. Coumarin Derivatives

Warfarin Sodium 1MG Tablet

2.5MG Tablet

2MG Tablet


Warfarin Sodium 3MG Tablet

5MG Tablet

20:12.04.12 Direct Thrombin Inhibitors

Argatroban 100MG/ML Vial LASA

20:12.04.14 Direct Factor Xa Inhibitors

Fondaparinux 2.5MG/0.5ML Syringe

20:12.04.16. Heparins

Heparin Sodium 5000 IU IN 0.2 ML

Vial HAM, LASA

5000 IU/ML IN 5 ML

Vial HAM, LASA

1000 I.U./ML, 5ML

Vial HAM, LASA

Enoxaparin 20MG(2000IU) Pre-filled syringe

40MG(4000IU) Pre-filled syringe

60MG (6000IU) Pre-filled syringe

80MG (8000IU) Pre-filled syringe


20:12.18. Platelet-Aggregation Inhibitors

Aspirin (Acetylsalicylic Acid) 81MG-100MG Tablet

Clopidogrel 75MG Tablet

20:12.20. Thrombolytic Agents

Alteplase (Rtpa) 50MG/50ML Vial

Aspirin 81MG-100MG tablet

Streptokinase 1,500000 I.U. Vial

20:16. Hematopoietic Agents

(1000) I.U. Vial

(10000) I.U. Vial

(2000 ) I.U. Vial

(4000) I.U. Vial

(40000) I.U. Vial

20:28. Antihemorrhagic Agents

20:28.08 - Antiheparin Agents

Protamine sulphate Vial

Recombinant human erythropoietin


20:28.16 Hemostatics

Aprotinin 0.5MG/1ML Vial

500,000IU, 50ML

Vial

20:28.16 - Hemostatics

Aminocaproic acid 250 MG./ ML Ampule AUR

Antihemophilic factor VIIA Human

LYOPHILIZED

Antihemophilic Factor IX Human 500 IU Vial

Antihemophilic Factor VIII (Recombinant)

1000 IU Vial

250 IU Vial

500 IU Vial

Anti-Rho(D) Immunoglobulin (200-300 MCG) Injection

Ethamsylate 250MG/2ML Ampule

Tranexamic acid 500MG Tablet

100MG/ML, 5ML

Injection

24:00 - Cardiovascular DrugsCLASS/DRUG STRENGTH FORM STATUS

24:04 - Cardiac Drugs

24:04.04: Antiarrhythmic Agents

24:04.04.04. Class Ia Antiarrhythmics

Procainamide HCL 100MG/ML, 10ML

Injection

Quinidine sulphate 200 MG Tablet

Disopyramide (As Phosphate) 100-150 MG Capsule AUR

24:04.04.08. Class Ib Antiarrhythmics

Lidocaine 1% Injection

Lidocaine 4% Topical Solution

Lidocaine 1% Pre-filled syringe

Lidocaine 2% 20MG/ML, 20ML

Injection

2%, 5ML Pre-filled syringe

Lidocaine 2GM IN 500ML D5W

Premixed Bag

Phenytoin 250MG/5ML Injection

24:04.04.16. Class II Antiarrhythmics


50MG Tablet

25MG Tablet



5MG Tablet

2.5MG Tablet


Vial HAM



50MG Tablet


5MG/ML, 20ML Injection

24:04.04.20. Class III Antiarrhythmics

Amiodarone 150MG/3ML Ampule LASA

200MG Tablet LASA

Bretylium Tosylate 500MG/10ML Vial

24:04.04.24. Class IV Antiarrhythmics

Adenosine 6MG/2ML Vial

Diltiazem Hcl 5MG/ML Vial

Verapamil Hcl 5 MG/2 ML Ampoule HAM


24:04.04.92. Antiarrhythmics, Miscellaneous

Digoxin 500 MCG/2ML Injection

24:04.08. Cardiotonic Agents

Digoxin (PAEDIATRIC) 0.05 MG./ ML. IN 60 ML

Elixer

Digoxin 0.0625MG Tablet

0.125MG Tablet

0.25MG Tablet

500MCG/2ML Injection

DOBUTamine 500MG IN 250ML D5W

Premixed Bag

HAM, LASA

500MG IN 250ML D5W

Premixed Bag

HAM, LASA

DOBUTamine HCL 250 MG Injection HAM, LASA

DOPamine HCl 400MG, 250ML D5W

Premixed Bag

HAM, LASA

800MG, 250MG D5W

Premixed Bag

40 MG/ML IN 5 ML (200 MG)

vial

Milrinone 10MG/10ML Injection

24:06 - Antilipemic Agents

24:06.06 Fibric Acid Derivatives

Fenofibrate 145MG Tablet


24:06.08 - HMG-CoA Reductase Inhibitors

SIMVAstatin 10MG Tablet LASA

20MG Tablet LASA

40MG Tablet LASA

ATORVAstatin 10MG Tablet LASA

20MG Tablet LASA

40MG Tablet LASA

24:08 - Hypotensive Agents

24:08.04 - -Adrenergic Blocking Agents



24:08.08 - -Adrenergic Blocking Agents


50MG Tablet

25MG Tablet


Vial





100MG Tablet


24:08.12 - Calcium-Channel Blocking Agents

AmLODIPine 5MG Capsule LASA

AmLODIPine Besylate 10MG Capsule LASA

Nicardipine 25MG/10ML Ampoule

NIFEdipine Retard 20MG Tablet LASA

NIFEdipine LA 30MG Tablet LASA

60Mg Tablet LASA

24:08.12.92 Calcium-Channel Blocking Agents, Miscellaneous

Diltiazem 30MG Tablet

60MG Tablet

90MG Tablet

Diltiazem Hcl 5MG/ML Injection

Verapamil 40MG Tablet

Labetalol


Verapamil Hcl 5MG/2ML Ampoule HAM

24:08.16 - Central -Agonists

CloNIDine HCL 100MCG Tablet LASA, AUR

CloNIDine HCL 150MCG Tablet LASA, AUR

CloNIDine HCL 150MCG/ML Vial LASA, AUR

Methyldopa 250MG Tablet

24:08.20 - Direct Vasodilators

HydrALAZINE 20MG/1ML Vial HAM, LASA

25MG Tablet HAM, LASA

Minoxidil 2 % (60ML) Solution

5 % (60ML) Solution

Nitroprusside 50MG Injection

24:08.24 - Diuretics (Cardiovascular Drugs)

24:08.24.08 Loop Diuretics

Furosemide Syrup 1MG/ML, 100 ML

Syrup

Furosemide 20MG/2ML Ampule

40MG Tablet


24:08.24.12 Osmotic Diuretics (Cardiovascular Drugs)

Mannitol 10% 500Ml Bottle

20% 500Ml Bottle

24:08.24.16 Potassium Sparing Diurectics (Cardiovascular Drugs)

AMILoride, Hydrochlorothiazide 5MG, 50MG Tablet LASA

Spironolactone 100MG Tablet

25MG Tablet

24:08.24.20 Thiazide Diuretics (Cardiovascular Drugs)

Hydrochlorothiazide 25MG Tablet

24:08.24.24 Thiazide-like Diuretics (Cardiovascular Drugs)

Indapamide 1.5MG Tablet

Metolazone 5MG Tablet

24:08.24.92 Diuretics, Miscellaneous (Cardiovascular Drugs)

Theophylline 200MG Tablet

Theophylline Hydrate 60MG/5ML,300ML

Liquid


24:08.44. Renin-Angiotensin-Aldosterone System Inhibitors

24:08.44.04 Angiotensin-Converting Enzyme Inhibitors

Enalapril 10MG Tablet

20MG Tablet

5MG Tablet

Perindopril 5MG Tablet

24:08.44.08. Angiotensin II Receptor Antagonists

Candesartan 16 MG Tablet

8 MG Tablet

Irbesartan 150 MG Tablet

300 MG Tablet

Losartan 100MG Tablet

50MG Tablet

Valsartan 160 MG Tablet

80 MG Tablet

160MG, 12.5MG Tablet

80MG, 12.5MG Tablet

24:08.44.20. Mineralocorticoid (Aldosterone) Receptor Antagonists


25MG Tablet

Valsartan, Hydrochlorothiazide


24:12 - Vasodilating Agents

24:12.08. Nitrates and Nitrites

Isosorbide Dinitrate 20MG Tablet

5MG Subligual Tablet

Nitroglycerin 50MG Vial

25MG/10CM Patch

0.5MG Subligual Tablet

24:12.12 Phosphodiesterase Type 5 Inhibitors

Sildenafil 50Mg Tablet

24:12.92. Vasodilating Agents, Miscellaneous

Alprostadil (PGE1) Paediatric 0.5 MG/ML IN 1 ML

Ampoule

Bosentan 125 Mg Tablet AUR

Papaverine 30mg/ml Injection


60MG Tablet

90MG Tablet



Verapamil Hcl 5MG/2ML Ampoule HAM


24:20 - -Adrenergic Blocking AgentsTerazosin 2MG Tablet


25MG Tablet LASA

6.25MG Tablet LASA



24:24 - -Adrenergic Blocking AgentsPropranolol 1MG/ML Injection HAM

10MG Tablet

40MG Tablet


50MG Tablet

25MG Tablet


2.5MG Tablet

5MG Tablet


25MG Tablet LASA




Vial



50MG Tablet



Bisoprolol, Hydrochlorothiazide 5MG, 12.5MG Tablet

24:28 - Calcium-Channel Blocking Agents

24:28.08. Dihydropyridines

AmLODIPine 5MG Tablet LASA

AmLODIPine besylate 10MG Capsule LASA

Nicardipine 25MG/10ML Ampoule

NIFEdipine Retard 20MG Tablet LASA

NIFEdipine LA 30MG Tablet LASA

60MG Tablet LASA


24:28.92. Calcium-Channel Blocking Agents, Miscellaneous


60MG Tablet

90MG Tablet



Verapamil Hcl 5 MG/2 ML Ampoule HAM

24:32 - Renin-Angiotensin-Aldosterone System Inhibitors

24:32.04. Angiotensin-Converting Enzyme (ACE) Inhibitors

Captopril 25MG/5ML, 100ML

Suspension LASA

25MG Tablet LASA

50MG Tablet LASA

Enalapril 10MG Tablet

20MG Tablet

5MG Tablet

Lisinopril 5MG Tablet

10MG Tablet

20MG Tablet

Perindopril 5MG Tablet


24:32.08. Angiotensin II Receptor Antagonists

Candesartan 16MG Tablet

8MG Tablet

Irbesartan 150MG Tablet

300MG Tablet

Losartan 100MG Tablet

50MG Tablet

Valsartan 160MG Tablet

80MG Tablet

160MG, 12.5MG Tablet

80MG, 12.5MG Tablet

24:32.20. Mineralocorticoid (Aldosterone) Receptor Antagonists


25MG Tablet

Valsartan, Hydrochlorothiazide

28. Central Nervous System Agents

28. Central Nervous System Agents CLASS/DRUG STRENGTH FORM STATUS

28:04: General Anesthetics

28:04.04. Barbiturates

Thiopental Sodium 500 MG/Ampoule

Injection

28:04.16 Inhalational Anesthetics

Desflurane 250 ML Bottle HAM

Sevoflurane 250 ML Bottle

28:04.92. General Anesthetics, Miscellaneous

Etomidate 2MG/ML, 10ML Vial

Etomidate 2MG/ML, 20ML Vial

Ketamine 50MG/ML Injection

Propofol 1 % 10 MG/ML IN 20 ML

Injection HAM

1% 10MG/ML 50 ML

Injection HAM

2% 50ML Vial Injection HAM

28:04 Analgesics and Antipyretics

28:08.04 Nonsteroidal Anti- Inflammatory Agents

28:08.04.08. Cyclooxygenase-2 (COX-2) Inhibitors

Celecoxib 200MG Capsule


28:08.04.24. Salicylates

Aspirin 81MG-100MG Tablet

28:08.04.92. Other Nonsteroidal Anti-inflammatory Agents100MG Tablet

12.5MG Suppository

50MG Tablet

1% Gel

100MG Suppository

15MG/3ML Ampule

Diclofenac Epolamine Patch AUR

Ibuprofen 100MG/5ML, 100ML

Syrup

400MG Tablet

Ibuprofen Lysine 15mg/ML Vial

Indomethacin 100MG Suppository

25MG Capsule

1 MG/Vial Injection

50 MG/Vial Injection

Mefenamic Acid 250MG Capsule

Diclofenac

Diclofenac Sodium


Meloxicam 15MG Tablet

7.5MG Tablet

Ketorolac 30MG 1ML Vial LASA

28:08.08 Opiate Agonists

Acetaminophen-Codeine 300/30 mg Tablet

Acetaminophen (Paracetamol), Codeine

120MG, 12MG/5ML

Syrup

Alfentanil 0.5MG Ampoule

Codeine 30MG Tablet

FentaNYL 100MCG Ampule LASA

25MCG Dermal patches

LASA


LASA


LASA

50MCG/ML,2ML vial LASA

Morphine Sulphate 10MG/5ML Syrup LASA

10MG Tablet LASA


Morphine Sulphate 30MG S.R. Tablet LASA

5MG/ML Injection LASA

10Mg/Ml,1Ml Ampoule LASA

Methadone 5MG Tablet LASA

oxyCODONE 5MG Tablet LASA

Pethidine (Meperidine) 100MG/2ML Injection

50MG/1ML Injection

Remifentanil 2MG Vial

5MG Vial

Sufentanil 0.05MG Ampoule LASA

TraMADol 100MG Tablet

50MG Tablet

50MG/2ML Injection

100MG Suppository

28:08.12 Opiate Partial Agonists

Nalbuphine 20MG Ampoule


28:08.92 Analgesics and Antipyretics, Miscellaneous

Acetaminophen (Paracetamol) 10 MG/ML 100 ML (1GM)

Vial

500mg Vial

125MG Suppository

250MG Suppository

350MG Suppository

500MG Suppository

500MG Tablet

120MG/5 ML Syrup

120mg/5ml Oral Drops

Acetaminophen (Paracetamol), Codeine

120MG/12MG /5ML

Syrup

Chlorzoxazone,Acetaminophen (Paracetamol)

250 mg / 300mg

Capsule

Gabapentin 300MG Capsule

400MG Capsule

28:10. Opiate AntagonistsNaloxone 0.02MG/ML Injection

0.4MG/ML Injection


28:12 ANTICONVULSANTS

28:12.04 Barbiturates, Anticonvulsants

Phenobarbitone 30MG/10ML, 500ML

Syrup

10MG Tablet

100MG Tablet

200MG/ML Injection

20MG/5ML Bottle

28:12.08 Anticonvulsants - Benzodiazepines

ALPRAZolam 0.25MG Tablet C, LASA

0.5MG Tablet C, LASA

ClonazePAM 0.5MG Tablet C, LASA

2MG Tablet C, LASA

2.5MG/ML,10ML

Drops C, LASA

Diazepam 2MG Tablet C

5MG Tablet C

10MG Tablet C

10MG/2ML Ampule C

2MG/5ML Syrup C

5 MG/TUBE Rectal solution

C


Midazolam 2MG/ML Injection C

5MG/ML Injection C

LORazepam 1MG Tablet C, LASA

2MG Injection C, LASA

28:12.12 Anticonvulsants - Hydantoins 100MG Capsule

250MG/5ML Injection

30MG/5ML Syrup

28:12.20 Succinimides

Ethosuximide 250MG Capsule AUR

50MG/ML Syrup

28:12.92 Miscellaneous Anticonvulsants

CarBAMazepine 200MG Tablet LASA

400MG Tablet CR LASA

100 MG/5 ML 100 ML

Syrup LASA

Phenytoin


Gabapentin 300MG Capsule

400MG Capsule

LamoTRIgine 100MG Tablet LASA

50MG Tablet LASA

LevETIRAcetam 100MG Syrup LASA

500MG Tablet LASA

Magnesium Sulphate 500MG/ML (50%), 5Ml

Ampoule

Pregabalin 150MG Capsule

75MG Capsule

Topiramate 100MG Tablet

15MG Capsule

25MG Tablet

Valproate sodium 200MG Tablet

500MG Tablet SR

200MG/ML Oral solution

250 MG/5ML Syrup

400MG/4ML Injection


28:16. Psychotherapeutic Agents28:16.04 Antidepressants

28:16.04.20. Selective Serotonin-reuptake Inhibitors

Escitalopram 10MG Tablet

PARoxetine 20 MG Tablet LASA

28:16.04.28. Tricyclics and Other Norepinephrine-reuptake Inhibitors

Amitriptyline HCL 10MG Tablet

25 MG Tablet

50MG

28:16.08 Antipsychotic Agents

28:16.08.04 Atypical Antipsychotics

Clozapine 100MG Tablet AUR

OLANZapine 10MG Tablet AUR

5MG Tablet AUR

QUEtiapine 100MG Tablet LASA

300MG Tablet LASA

RisperiDONE 2MG Tablet AUR

4MG Tablet AUR


28:16.08.08 Butyrophenones

Haloperidol 1.5MG Tablet

5MG Tablet

2MG/ML,15ML Drops

5MG/ML vial

28:20. Anorexigenic Agents and Respiratory and CNS Stimulants

28:20.32. Respiratory and CNS Stimulants

Doxapram 20MG/ML, 20ML

Vial

Methylphenidate 10MG Tablet

18MG Tablet

36MG Tablet

28:20.92 Anorexigenic Agents and Respiratory and Cerebral Stimulants,Miscellaneous

Caffeine Citrate 20MG/ML, 3ML Oral Solution

20 MG/ML, 3ML Vial

28:24. Anxiolytics, Sedatives, and Hypnotics

28:24.04. Barbiturates

PHENobarbital 30MG/10ML, 500ML

Syrup C, LASA


PHENobarbital 10MG Tablet C, LASA

100MG Tablet C, LASA

200MG/ML Injection C, LASA

20MG/5ML Bottle C, LASA

28:24.08. Benzodiazepines

ALPRAZolam 0.25MG Tablet C, LASA

0.5MG Tablet C, LASA

Clobazam 10MG Tablet LASA

chlordiazePOXIDE 5MG Tablet LASA

ClonazePAM 0.5MG Tablet C, LASA

2MG Tablet C, LASA

2.5MG/ML Drops C, LASA

Diazepam 10MG Tablet C

10MG/2ML Injection C

2MG Tablet C

2MG/5ML Syrup C

5MG Tablet C

5 MG/TUBE Rectal tube C


LORazepam 1MG Tablet C, LASA

2MG Injection C, LASA

Midazolam 2MG/ML Injection C

5MG/ML Injection C

28:24.92. Anxiolytics, Sedatives, and Hypnotics; Miscellaneous

Chloral Hydrate 500MG/5ML Syrup

40MG Bottle

hydrOXYzine 10MG Tablet LASA

Promethazine 25MG/ML, 2ML Injection

Propofol 1 % 10 MG/ML IN 20 ML

Injection HAM

1% 10MG/ML 50 ML

Injection HAM

2%, 50ML Injection HAM

Zolpidem 10MG Tablet

28:28. Antimanic AgentsCarBAMazepine 200MG Tablet LASA

400MG Tablet CR LASA

100 MG/5 ML 100 ML

Syrup LASA


Valpoate sodium 200MG Tablet

500MG Tablet SR

200MG/ML Oral drops

250 MG/5ML Syrup

400MG/4ML Injection

28:32. Antimigraine Agents

28:32.28. Selective Serotonin Agonists

SUMAtriptan 50MG Tablet LASA

28:32.92. Antimigraine Agents, Miscellaneous

Ergotamine Tartrate , Caffeine 1 MG, 100 MG Tablet

Propranolol 10MG Tablet

40MG Tablet

Topiramate 100MG Tablet

15MG Capsule

25MG Tablet


Valproate sodium 200MG Tablet

500MG Tablet SR

200MG/ML Oral solution

250 MG/5ML Syrup

28:36. Antiparkinsonian Agents

28:36.04. Adamantanes

Amantadine 100MG Capsule LASA

28:36.08. Anticholinergic Agents

Benztropine 1MG/ML IN 2 ML Injection

Benztropine MESYLATE 2MG Tablet

Trihexyphenidyl 2MG Tablet

5MG Tablet

28:36.12. Catechol-O-Methyltransferase (COMT) Inhibitors

Levodopa, Carbidopa, and Entacapone

200MG, 50MG, 200MG

Tablet


28:36.16. Dopamine Precursors

Carbidopa, Levodopa 100MG, 25MG Tablet

200MG, 50MG Tablet

250MG, 25MG Tablet

Levodopa, Carbidopa, and Entacapone

200MG, 50MG, 200MG

Tablet

50MG, 12.5MG, 200MG

Tablet

28:36.20. Dopamine Receptor Agonists

28:36.20.04 Ergot-derivative Dopamine Receptor Agonists

Bromocriptine 2.5MG Tablet

Cabergoline 500MCG Tablet

28:40. Fibromyalgia Agents150MG Capsule R

75MG Capsule R

Pregabalin


28:92. Central Nervous System Agents, MiscellaneousFlumazenil 0.5MG/5ML Ampule LASA

32:00 Contraceptives (Foams, devices, etc)Desogestrel 75 MCG Tablet

36: Diagnostic AgentsCLASS/DRUG STRENGTH FORM STATUS

36:40 Kidney Function Mannitol 10% 500Ml Bottle

20% 500Ml Bottle

36:56. Myasthenia GravisEdrophonium Chloride 10MG/ML Injection

Neostigmine 2.5MG/ML Ampoule

Neostigmine Methyl sulphate 0.5 MG/ML IN 1 ML

Ampoule

36:58 Ocular DisordersFluorescein and Lidocaine 4% , 0.25% Eye drops

Flourescein 0.25% Minims

Trypan Blue Ophthalmic Solution (Intraocular Capsule

0.6MG/ML Solution

36:84. TuberculosisTuberculin (PPD) Skin Tests 5 tuberculin

units / 0.1ml -1 ml

Injection LASA

36: Diagnostic AgentsCLASS/DRUG STRENGTH FORM STATUS

36:68 Contrast Media Barium Sulfate For Ugi 98% Suspension

Barium-Based Contrast Media For Enteroclysis

50% W/V Kit

Gadopentetic Acid (Magnevist), Non-Ionic, For MRI

20Ml Injection

Iobitridol, Non-Ionic, For Ct Scan

300Mg/Ml 50Ml Injection

Barium Sulfate Suspension For Ct Examinations Of The Gastrointestinal Tract

1.3% W/V (400 Ml)

Enema Kit W/ Barium Sulfate Suspension

Barium Sulfate Suspension For Computed Tomography Of Gastrointestinal Tract

1.3-1.5% W/V (450 Ml )

Suspension

Barium Sulfate Suspension For Double Contrast Colon Examinations

105% W/V (1900 Ml/Gallon)

Suspension

Sodium Diatrizoate (Gastrografin)

120ML bottle

Sodium Amidotrizoate, Meglumine Amidotrizoate (Urografin)

146Mg/Ml 30% 250Ml.

Injection

40. Electrolytic, Caloric, and Water Balance CLASS/DRUG STRENGTH FORM STATUS

40:04: Acidifying AgentsAmmonium chloride 5MEQ/ML, IN 20

MLSolution for injection

Ringer's Lactate 500ML Bottle

40:08. Alkalinizing Agents Sodium Bicarbonate 1 KG Jar

1 MEQ/ML, 10 ML

Prefilled syringe

Sodium Acetate 2MEQ/ML 20ML, 4 MEQ/ML 50ML

Vial

325MG Tablet

8.4% [1MMOL/1ML] 50ML

Syringe

Potassium Citrate (Urocit K) 10meq/tablet Tablet

Ringer's Lactate 1000ML Bag

Ringer's Lactate IV 500ML Bag

40:10. Ammonia DetoxicantsLactulose 3.35GM/5ML Syrup

Sodium Benzoate 500 GM Oral powder


40:12. Replacement PreparationsCalcium and Vitamin D Tablet

Calcium Carbonate 600MG Tablet

Calcium Chloride 0.9% IV (10ML) Vial

10% (10 ML) Prefilled syringe

10% Vial

Calcium Gluconate 10% 10ML Ampoule

Calcium Gluconate + Calcium Glubionate

1.2 G/5ML Syrup

Calcium polystyrene sulphonate (Calcium Resonium Powder)

Powder

Dextran LMW 500ml Bottle

Hydroxyethyl starch penta starch

6% 500 ML Solution

Oral rehydration electrolyte Sachet

Oral rehydration electrolyte Solution

Magnesium Sulphate 500MG/ML (50%), 5Ml

Ampoule

Magnesium Sulfate Kit 50%, 4 mEq/ML, 50ML

Vial

Magnesium Hydroxide 1200MG Syrup

Potassium Chloride 600MG Tablet


Potassium Chloride 2MEQ/ML, 10ML

Injection

120ML Syrup

Potassium Phosphate for TPN 4.4 MMOL/ML Injection

Potassium Phosphate 45Mm/15ml + 66 mEq/15

Injection

Sodium polystyrene sulfonate 454G Powder

Sodium Glycerophosphatel (Glycophos)

1Mmol P /Ml ,20ML

Vial AUR

Sodium Phosphate 45 mMol/15 ml Injection

Sodium Phenyl Acetate, Sodium Benzoate

10%, 10 % Ampoule AUR

Phosphate Sandoz 500MG Tablet

Sodium Chloride 0.9% 30ML Nasal spray

0.9% 100 ML Bag

0.9% 50 ML Bag

0.9 % 500 ML Bag

0.9% 500ML Bag

0.9% (1000ML)

Bag

0.9% (100ML) Bag

Sodium Chloride 0.9% 250ML Bag


Sodium Chloride 0.45% (500ML)

Bag

0.45% IV (1000ML)

Bag

14.60% Solution

Sodium Chloride Hypertonic solution

3% 500Ml Bottle

Sodium Thiosulfate 50 % 12.5 G/AMPOULE, 25ML

Ampoule

Sterile water for injection 1000ML Bag

10ML Ampoule

40:18. Ion-removing Agents

40:18.18. Potassium-removing Agents

Calcium polystyrene sulphonate (Calcium Resonium Powder)

Powder

Sodium polystyrene sulfonate 454G Powder

40:18.19. Phosphate-removing Agents

Calcium Carbonate 100MG/ML, 500ML

Syrup

600MG Tablet

Calcium Chloride 10% (10 ML) Prefilled syringe

10% Vial

Calcium Gluconate 10% 10ML Ampoule


40:20: Caloric AgentsAmino Acids crystalline Injection (Essential and 7 at

15% IN HYPERTONIC Solution 100ML

Solution

Amino Acids crystalline Injection (Essential and 7 at

10% IN HYPERTONIC Solution 100ML

Solution

L-Carnitine 200 MG/ML Injection

300MG/ML, (20 ML)

Oral Solution

Fat Emulsion (MCT/LCT) 20% 500ML Vial

Dextrose 5% 100 ML Bag

5% 50ML Bag

10%, 500ML Bag

50%, 50ML Vial

Dextrose, normal saline 5%, 0.225% (500ML)

Solution

Dextrose In Normal Saline 10% Solution

Dextrose, Sodium Chloride 5%, 0.45% (500 ML)

Solution

Dextrose Solution, normal saline

5%, 500 ML Solution

Dextrose 5%, 500 ML Bag

Dextrose IV 500 ML Bag 10%, 500ML Bag


40:28. Diuretics

40:28.04. Carbonic Anhydrase Inhibitors

AcetaZOLAMIDE 250MG Tablet LASA

500 MG/Vial Injection LASA

40:28.08. Loop Diuretics

Furosemide 1MG/ML, 100 ML

Syrup

20MG/2ML Injection

40MG Tablet

40:28.12 Osmotic Diuretics

Mannitol 10% 500Ml Bottle

20% 500Ml Bottle

40:28.16. Potassium-sparing Diuretics

AMILoride 5MG Tablet LASA


25MG Tablet

40:28.20. Thiazide Diuretics

Hydrochlorothiazide 25 MG Tablet


40:28.24. Thiazide-like Diuretics

Indapamide 1.5MG Tablet

40:28.92. Diuretics, Miscellaneous


Theophylline Hydrate 60MG/5ML,300ML

Liquid

40:36. Irrigating SolutionsGlycine Solution 1.5% IN

3000MLBag Solution

Glycine Powder 1 Kg Bottle AUR

Sodium Chloride 0.45% 500ML Bottle

0.90% Bottle

Sodium Chloride Soution 0.45% IV (1000ML)

Bag

Sterile Water for Irrigation 1000 ML Bottle

44. EnzymesCLASS/DRUG STRENGTH FORM STATUS

Alteplase (Rtpa) 50MG/50ML Injection

Streptokinase 1,500000 I.U. Vial

48:00 Respiratory Tract Agents CLASS/DRUG STRENGTH FORM STATUS

48:04. Antihistamines (Respiratory Tract)

48:04.04 First Generation Antihistamines(Respiratory Tract)

DiphenhydrAMINE (Systemic) 50MG/ML, 1ML Vial LASA

25MG Capsule LASA

48:04.08 Second Generation Antihistamines (Respiratory Tract)

Triprolidine, Pseudoephedrine 1.25MG, 30MG/5ML

Syrup

48:08. AntitussivesGuaifenesin, Dextromethorphan

118ML Syrup LASA

Dextromethorphan 15MG/5ML Syrup

DiphenhydrAMINE, Ammonium chloride, Menthol

14MG, 135MG, 1.1MG

Syrup LASA

DiphenhydrAMINE, Menthol 7MG, 0.55MG Syrup LASA

48:10. Anti-inflammatory Agents(Respiratory Tract)

48:10.08. Corticosteroids (Respiratory Tract)

48:10.08.04. Nasal Preparations

Fluticasone propionate 50MCG Nasal spray


Mometasone Furoate 0.05% Nasal spray

48:10.08.08. Orally Inhaled Preparations

Budesonide, Formoterol 160 MCG/4.5 MCG

Turbohaler

Budesonide 200MCG/PUFF Turbohaler

250 MCG/ML 2ML

Nebulizer

500MCG/ML NEBULIZER

48:10.24. Leukotriene Modifiers

Montelukast 10MG Tablet

4MG Chewable Tablet

5MG Chewable Tablet

48:12. Bronchodilators

48:12.04. Adrenergic Agents (Respiratory Tract)

48:12.04.12. Selective beta-2-Adrenergic Agonists (Respiratory Tract)

Salbutamol (Albuterol) 100MCG, (200 DOSES)

Inhaler


Salbutamol (Albuterol) 0.5% IN 20ML Nebulizer Solution

500 MCG / ML INJECTION

Formoterol Fumarate Dihydrate, Budesonide

4.5 MCG/160 MCG

Turbohaler

48:12.04.16. alpha- and beta-Adrenergic Agonists (Respiratory Tract)

ePHEDrine Sulphate 50MG/ML - 1ML Vial HAM, LASA

EPINEPHrine 1:1000(1MG/1ML),1ML

Ampule HAM, LASA

1:10000 (0.1MG/1ML), 10ML

Ampule HAM, LASA

48:12.08. Anticholinergic Agents(Respiratory Tract)

Atropine Sulphate 0.1MG/ML, (10ML)

Prefilled syringe

Atropine Sulphate 0.1Mg/Ml (5Ml) Prefilled Syringe

0.5MG Ampule

1MG/ML Ampule

Ipratropium bromide 20MCG/PUFF Inhaler

250MCG/2ML Vial

500MCG/2ML Solution Ampule

Ipratropium bromide, Fenoterol Hydrobromide

20 MCG, 50 MCG Metred dose Inhaler


48:12.12. Xanthine Derivatives


Theophylline Hydrate 60MG/5ML Liquid

Aminophylline 250MG/10ML Vial

48:16. ExpectorantsGuaifenesin, Dextromethorphan

118ML Syrup

DiphenhydrAMINE,Ammonium chloride, Menthol

14MG, 135MG, 1.1MG

Syrup

DiphenhydrAMINE, Menthol 7MG, 0.55MG Syrup

48:24. Mucolytic AgentsAcetylcysteine 200MG/ML,

10MLAmpoule

Bromhexine Hcl 4MG/5ML Syrup

48:48: Vasodilating AgentsBosentan 125 Mg Tablet

Sildenafil 50Mg Tablet


Iloprost 10MCG/ML Injection

20MCG/ML (1ML)

solution

48:36 Pulmonary SurfactantsBeractant (Survanta) 25mg/ml Vial

48:92 Respiratory Tract Agents, MiscellaneousOmalizumab 150 MG Vial

Racemic EPINEPHrine 2.25 %, 15ML Solution

52:00 - Eye, Ear, Nose, and Throat (EENT) PreparationsCLASS/DRUG STRENGTH FORM STATUS

52:02 Antiallergic AgentsKetotifen 5 ML Eye Drops

52:04. Anti-infectives

52:04.04. Antibacterials

Chloramphenicol 0.5%,10ML Eye drops

Chloramphenicol 1% Eye Ointment

Erythromycin 0.50% 3.5G Eye Ointment

Fusidic acid ophthalmic 1% Eye viscous drops

Fucidic Acid 1% 5GM Eye drops

Gatifloxacin 0.3% 5ML Eye drops

Gentamicin minims 0.30% Eye drops LASA

Moxifloxacin 0.50% Eye drops

Neomycin, gramicidin, nystatin, triamcinolone

2.5mg/0.25mg/100000u/ 1mg/g.

Eye drops

Neomycin, Polymyxin B, and Dexamethasone

Eye drops

Ofloxacin 0.3%, 5 ML/BOTTLE

Eye drops

Polymyxin B ,Neomycin Ophthalmic Solution

Tobramycin 0.3% , 3.5Gm Eye Ointment


52:04.16. Antifungals

Nystatin 100,000 I.U./ML

Suspension LASA

52:04.92. Anti-infectives, Miscellaneous

Chlorhexidine gluconate sodium 0.2 % IN 150 - 200 ML/BOTTLE

Mouth wash

Silver Nitrate Cautery Cautery

52:08. Anti-inflammatory Agents

52:08.08. Corticosteroids

Budesonide, formoterol 160MCG/4.5MCG

Turbohaler

dexamethasone ophth 0.5MG/GM (0.05%) 3 GM

Eye Ointment

Dexamethasone, Ofloxacin 3.1 /MG Eye drops

Fluorometholone (FML) 0.10% 5ML Eye drops

Fluticasone propionate 50 MCG Inhaler

125MCG Inhaler

250 MCG Inhaler

Fluticasone propionate 50MCG Nasal spray

Hydrocortisone Sodium Succinate

100MG Ampoule

Mometasone Furoate 0.05% Nasal spray


PrednisoLONE 1% Eye drops

Triamcinolone 40MG /ML Intraocular

52:08.20 Nonsteroidal Anti-inflammatory Agents (EENT)

Diclofenac Sodium 0.1% 0.3ML Eye drops

52:16. Local AnestheticsFluorescein 2% Minims

0.25% Minims

Benoxinate (Oxybuprocaine) 0.40% Minims

52:24. MydriaticsAtropine ophth 1% (10ML) Eye drops

Cyclopentolate Hcl 1 % 10-15 ML Eye drops

1% Minims

Tropicamide 0.10% Minims


52:28. Mouthwashes and GarglesChlorhexidine gluconate sodium 0.2 % IN 150 -

200 ML/BOTTLE

Mouth wash

52:32. VasoconstrictorsNaphazoline, chlorpheniramine maleate

0.05,0.05% Nasal drops

Naphazoline, pheneramine maleate

0.025,0.3% Eye drops

Xylometazolin 100MG Nasal drops

Xylometazolin for adult 1MG Nasal drops

for children 0.5MG Nasal drops

52:40. Antiglaucoma Agents

52:40.04 Alpha Adrenergic Agonist

Brimonidine 0.15% 5ML Eye drops

52:40.08: beta-Adrenergic Blocking Agents

Timolol preservative free 0.25% Eye drops


Timolol preservative free 1% 5ML Eye drops

52:40.12 Carbonic Anhydrase Inhibitors

Brinzolamide Preservative Free Drops

1% 5ML Eye drops

Dorzolamide 2% (5 ML) Eye drops

Dorzolamide, Timolol 2%, 0.5% Eye drops

52:40.20: Miotics

Carbachol 0.01%. Intraocular

Acetylcholine Chloride Intraoccular

1% Intraocular AUR

52:40.24 Osmotic Agents (EENT)

Mannitol 10% 500 ML Bottel

Sorbitol-Mannitol Irrigation 3000ML Bag

52:40.28 Prostaglandin Analogs

Latanoprost 0.01% Eye drops

Latanoprost, Timolol Maleate 50MCG, 5MG Eye drops


52:92. EENT Drugs, MiscellaneousBalanced Salt Solution (Bss) 500ML Solution

Docusate sodium 0.5% w/v Ear drops

Carboxymethyl Cellulose (Refresh Plus)

0.5%, 0.4ML Minims

White Petrolatum, Mineral Oil (Refresh P.m)

57.3%, 42.5% Ointment

Polyacrylic Acid 20MG Eye Gel tube

Sodium Chloride 0.9% 30ML Nasal spray

Hydroxypropyl methyl cellulose, Dextran (Tears Naturale)

0.3%,0.1% Eye drops

56.00 Gastrointestinal DrugsCLASS/DRUG STRENGTH FORM STATUS

56:04. Antacids and AdsorbentsActivated Charcoal 250MG - 300MG Tablet

Powder

Aluminum Hydroxide, Magnesium Hydroxide

405MG + 100MG/5ML

Suspension

400 MG/100 MG

Tablet

Magnesium oxide 400 MG Tablet

56:08. Antidiarrhea AgentsLoperamide 2MG Tablet

56:10. AntiflatulentsSimethicone Anti-flatulent Tablet

56:12. Cathartics and LaxativesBisacodyl 10MG Suppository

5MG Suppository

5MG Tablet


Castor Oil 60ML Bottle

Docusate Sodium 100MG Capsule

Fleet Enema Adult 135ML Enema

Pedia 60ML Enema

Glycerin Liquid

Glycerin Pediatric 900MG Suppository

Adult 1.8GM

Lactulose 3.35GM/5ML Syrup

Milk Of Magnesia Concentrated 1200 MG/15ML Bottle

Polyethylene Glycol-Electrolyte Bowel preparation (MoviPrep)

Sachet

Polyethylene Glycol-Electrolyte laxatives (Movicol)

Sachet

Psyllium Fiber Supplement (Orange Flavor)

174G Bottle

Senna 12MG Tablet

Sodium Phosphate as Phosphate

3MEQ/ML, 15 ML


56:14. Cholelitholytic AgentsUrsodeoxycholic acid 300MG Capsule

56:20. EmeticsIpecacuanha 30ML Syrup

56:22. Antiemetics

56:22.20 5-HT3 Receptor Antagonists4MG Ampoule

4MG Tablet

Granisetron 1MG/ML Ampoule

56:22.92 Antiemetics, Miscellaneous

Promethazine 25MG/ML, 2ML Injection

Hyoscine-N-Butylbromide 10 MG Tablet

20 MG/1 ML Ampoule

1MG/ML Syrup

Meclizine hydrochloride, pyridoxine hydrochloride

Tablet

Ondansetron


56:28. Antiulcer Agents and Acid Suppressants

56:28.12. Histamine H2-Antagonists

Ranitidine HCL 150MG Tablet

50MG Injection

56:28.28. Prostaglandins

Misoprostol 200MCG Tablet

100MCG Tablet

56:28.36. Proton-pump Inhibitors

Omeprazole 10MG Tablet LASA

20MG Tablet LASA

40MG Injection LASA

Esomeprazole 20MG Tablet

40MG Tablet

40MG Vial

56:32. Prokinetic AgentsMetoclopramide 10MG Tablet

4MG/ML,15ML Drops

5MG/5ML Syrup

10 MG/2 ML Ampoule


56:36. Anti-inflammatory AgentsMesalazine (Mesalamine) 800mg Tablet

2GM Sachet

1GM Suppository

SulfaSALAzine 500MG Tablet LASA

56:40 GI Drugs, MiscellaneousDomperidone 10MG Tablet

5MG/5ML Suspension

56:92. GI Drugs, MiscellaneousMebeverine 200MG Capsule

135MG Tablet

64:00 - Heavy Metal AntagonistsCLASS/DRUG STRENGTH FORM STATUS

Deferoxamine 500MG/VIAL Vial

Deferasirox 125 MG Tablet

68:00 - Hormones and Synthetic Substitutes CLASS/DRUG STRENGTH FORM STATUS

68:04. AdrenalsBudesonide, formoterol 160 MCG/4.5

MCG Turbohaler

Budesonide 200MCG/PUFF Turbohaler

250 MCG/ML 2ML

Nebulizer

500MCG/ML Nebulizer

Fludrocortisone Acetate 100MCG Tablet

Hydrocortisone 50MG/ML Vial

25MG Suppository

10 MG Tablet

Hydrocortisone Sodium Succinate

100MG Ampoule

MethylPREDNISolone acetate (Depo-Medrol )

40MG Vial LASA

MethylPREDNISolone sodium succinate (Solu-Medrol)

500MG Injection LASA

PrednisoLONE 20MG Tablet

5MG Tablet

15MG/5 ML Syrup

Tramcinolone acetonide 40 MG/ML Vial

Dexamethasone 4MG Tablet

Dexamethasone 4MG Ampoule


Dexamethasone 8MG/2ml Ampoule

Cyproterone Acetate + Ethinylestradiol

2MG/0.035MG Tablet

Ethinyl Estradiol, Drospirenone 1MG, 2MG Tablet

Desogestrel, Ethinyl estradiol 0.15 MG + 0.03 MG

Tablet

Dydrogesterone 10MG Tablet

MedroxyPROGESTERone Acetate

500MG Tablet

150MG/ML Vial

Non-Hormonal Intrauterine Contraceptive Device (Nova-T)

Device

Hormonal Levonorgestrel-Releasing Intrauterine Device (Mirena)

Device

68:16: Estrogens and Estrogen Agonists-Antagonists

68:16.04: Estrogens

Conjugated Estrogens 0.625MG Tablet

1.25 MG Tablet

68:12. Contraceptives


Conjugated Estrogens 0.625MG/GM Vaginal cream

ClomiPHENE 50mg Tablet LASA

Desogestrel+Ethinyl estradiol 0.15 MG + 0.03 MG

Tablet

Estradiol 25MCG Vaginal Pessary

68:18 Gonadotropins

Human Chorionic Gonadotrophin

5000 I.U Vial

Human Menopausal Gonadotrophin

75 I.U Injection

Leuprorelin 3.75MG Injection

7.5MG Injection

Acarbose 100MG Tablet

50MG Tablet

MetFORMIN 500MG Tablet LASA

850MG Tablet LASA

68:20. Antidiabetic Agents

68:20.04. Biguanides

68:20.02. alpha-Glucosidase Inhibitors


Sitagliptin 100MG Tablet

Insulin (NPH/SOL.) 30/70

100 UNITS/ML,3ML

Penfill cartridge

Insulin Aspart Solution (NovoRapid FlexPen.)

100 U/ML, 3ML Pre-filled pen

Insulin Glargine ,Solution (Lantus)

100 U/ML, 3ML Pre-filled pen

Insulin Human Isophane soluble(70/30)

10ML Vial

Insulin Human Isophane Suspension

100 UNITS/ML IN 10 ML

Vial

Insulin Human Regular 100 UNITS/ML IN 10 ML

Vial

Insulin soluble Human pen 100 IU/ML 3ML Pre-filled pen

Insulin aspart 100 UNITS/ ML, 10 ML

Vial

Glibenclamide (GlyBURIDE) 5MG Tablet LASA

Gliclazide MR 30 MG Tablet

Glimepiride 1MG Tablet

2MG Tablet

3MG Tablet


68:20.05 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

68:20.20. Sulfonylureas

68:20.08. Insulins

Pioglitazone 15MG Tablet

30MG Tablet

Bromocriptine 2.5MG Tablet

68:22.12 Glycogenolytic Agents

Glucagon 1MG/ML Vial

Diazoxide 50MG/ML Suspension AUR

68:24. ParathyroidCalcitonin 100UNITS/ML,

2ML Ampule

68:28. PituitaryVasopressin 20 UNITS/ML Vial

Desmopressin Acetate Melt 60MCG Tablet


68:22. Antihypoglycemic Agents

68:20.28. Thiazolidinediones

68:20.92. Antidiabetic Agents, Miscellaneous

Desmopressin Acetate 4MCG/ML Injection

68:36. Thyroid and Antithyroid Agents

68:36.04. Thyroid Agents25MCG Tablet

50 MCG Tablet

100 MCG Tablet

68:36.08. Antithyroid Agents

Carbimazole 5MG Tablet

68:32 ProgestinsHydroxyprogesterone Caproate

250MG/ML Vial

Progesterone 400MG Vaginal Pessary

Norethisterone (Primolut-N) 5 MG Tablet

Thyroxine sodium (Levothyroxine)

72:00 - Local Anesthetics CLASS/DRUG STRENGTH FORM STATUS

Lidocaine, EPINEPHrine 1%, 1:100,000 , 20ML

Injection

Lidocaine, EPINEPHrine 2%, 1:80000, 1.8 Ml

Injection AUR

Lidocaine (Topical) 2% (20G) Gel tube

10MG/SPRAY Aerosol

Lidocaine (Systemic) 1% 10 MG/ML, 20 ML

Injection

2% 20MG/ML, 20ML

Injection

2%, 5ML Prefilled syringe

Lidocaine, Prilocaine 2.5 %, 2.5% (5G)

Cream

Bupivacaine Heavy 0.5%, 4ML Vial

Bupivacaine 0.25% (20ML) Vial

0.5%, 20 ML Injection

Bupivacaine in Dextrose 5MG/ML DEXTROSE 8% (4 ML)

Ampoule

Bupivacaine With Epinephrine Injection

0.5%, 1:200,000

Injection AUR

Ropivacaine 2MG/ML Injection

76:00 Oxytocics CLASS/DRUG STRENGTH FORM STATUS

Dinoprostone E3 3MG Vaginal Insert

10MG Vaginal Insert

Carboprost Tromethamine 250mcg/ml Ampoule

Methylergometrine Maleate 0.2 MG/ML Ampoule

Oxytocin 10 UNITS/1ML Injection

Oxytocin and Ergometrine 5 UNITS, 0.5MG/1ML

Injection

Oxytocin Synthetic 5 IU/ML IN 1ML Ampoule

80. Serums, Toxoids, and Vaccines CLASS/DRUG STRENGTH FORM STATUS

80:04. SerumsAntivenin Scorpion (SCORPION VENOM ANTISERUM)

1ML Injection

Antivenin Snake (ANTIVENIN) 10ML Injection

Human ANTI-D Immune Globulin 1500 IU (300 MCG)

Injection

Human normal Immune Globulin 5 % I.V. 2.5 GM/50 ML

Injection

Digoxin Immune Fab (ANTIDIGOXIN FAB

40MG/Vial Injection

80:08. ToxoidsDiphtheria,Tetanus , Acellular Pertussis (DTaP), Toxoid

0.5ML Vial

Diphtheria,Tetanus, Pertussis Toxoid

0.5 ML Vial

Tetanus Toxoid 0.5 ML Vial

80:12. VaccinesHepatitis A Vaccine (for Adolescents and adults )

Vial

Hepatitis A Vaccine (for children)

Vial

Hepatitis B Vaccine (for Adolescents and adults )

Vial


Hepatitis B Vaccine (for children)

Vial

(Hexa Vaccine) Diphtheria, Hemophilus Influenzae B,

0.5ML Syringe

Measles Virus Vaccine 0.5 ML Vial

Measles, Mumps, and Rubella (MMR) Vaccine

0.5ML Vial

Meningococcal Vaccine 50MCG/0.5 ML Vial

Meningococcal and Diphtheria Conjugate Vaccine

Vial

Pneumococcal Vaccine 13 valent

0.5 ML Vial

Polio virus Vaccine oral (OPV) 0.5 ML Vial

Polio virus Vaccine S.C. (IPV)

Rabies Virus Vaccine 0.5 ML Vial

Varicella- zoster virus (Chickenpox vaccine)

0.5 ML Vial AUR

BCG Vaccine Vial

Diphtheria Tetanus Vaccine 0.5 ML Vial

Penta Vaccine (DPT+Hepatitis B, hib vaccine)

0.5ML Injection

Influenza Virus Vaccine Vial LASA


Rubella Vaccine Vial

Typhoid Vaccine 0.5 ML Vial

Yellow Fever Vaccine 0.5 ML Vial

Rotavirus Vaccine 1ML Vial

Measles, Mumps, Rubella And Varicella (Mmrv-Vaccine)

0.5ML Vial

84. Skin and Mucous Membrane AgentsCLASS/DRUG STRENGTH FORM STATUS

84:04 Anti-infectives

84:04.04. Antibacterials

Fusidate SOD. Skin 2 % 15 GM Ointment

Fusidic Acid 2 % 30 GM Cream

Fusidic Acid , Hydrocortisone acetate

2%, 1% (30 GM) Cream

Mupirocin 2 % (15 GM) Ointment

Nystatin, Neomycin, Gramcidine, Triamcinolone

(100000 U, 2.5MG, 0.25MG , 1GM)

Cream Or Ointment

MetroNIDAZOLE 0.75% Gel AUR, LASA

84:04.08. Antifungals

84:04.08.08 AzolesClotrimazole 1% Cream

100MG Vaginal pessary

0.5G Vaginal Tablet

500MG Vaginal Cream

Miconazole, Hydrocortisone 2%, 1% (30 GM) Cream

Miconazole 2%, 45 GM Vaginal Cream

2% Cream

2%, 40G Oral gel


Miconazole 400MG Vaginal ovule

Ketoconazole 2%, 120ML Shampoo

2% (20MG/GM) 30GM

Cream

84:04.12. Scabicides and Pediculicides

Crotamiton 10% IN 30 GM Cream

Pyrethrin anti Lice 50ML Bottle Shampoo

Permethrin 5 % (30-60 Gm)

Cream AUR

84:04.92. Local Anti-infectives, Miscellaneous

Silver Sulfadiazine (Flamazine) 1%, 50G Cream

Povidone-Iodine 5%10GM Ointment

5% w/v Sterile 30ML

Ophthalmic Solution

84:06: Anti-inflammatory AgentsBetamethasone Dipropionate 0.05 % (30 GM) Ointment

15GM Ointment

Betamethasone Dipropionate, Salicylic Acid

0.05%, 2 % IN 30ML

Scalp lotion

0.05% + 3% 15Gm

Ointment


Betamethasone Valerate 0.1 % (30 GM) Cream

Clobetasol Propionate 0.05% (25G ) Cream

Hydrocortisone 1% Cream

Hydrocortisone Butyrate Lipocream

0.1%. Cream AUR

Mometasone Furoate 0.1% 30GM Cream

0.10% lotion

0.10% Ointment

Triamcinolone Acetonide 0.1 % (15-30 GM)

Ointment

40MG/ML Vial

84:08: Antipruritics and Local AnestheticsCalamine Lotion lotion

Dimethindene Maleate Gel

84:12 AstringentsAluminum Chloride 20% Solution AUR

84:16 Cell Stimulants and Proliferants (Skin and Mucous Me

draft .pdf

Documents

nonformulary medication

kaauh drug formularyupdated

kaauh formularyrequest

example drugs

antihistamine drugs

health care professionals

promotion of health

health interests